Search
for
Sort by
Research 451–480 of 1000+
- Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
- Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
- Skin Cancer: Mechanisms and Human Relevance
- Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation
- A keratin 15 containing stem cell population from the hair follicle contributes to squamous papilloma development in the mouse
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- ALOPECIA AND ITS AYURVEDIC MANAGEMENT: A CASE REPORT
- Data from Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Data from Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human Skin
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- A Simple In Vivo System for Studying Epithelialization, Hair Follicle Formation, and Invasion Using Primary Epidermal Cells from Wild-Type and Transgenic Ornithine Decarboxylase-Overexpressing Mouse Skin
- Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis
- Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
- GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Supplementary Material for: GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia
- Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Hierarchically Assembled Nanofiber Scaffolds with Dual Growth Factor Gradients Promote Skin Wound Healing Through Rapid Cell Recruitment
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling
- Gender Differences in the Regulation of Blood Pressure
- Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists